Bottle Label (10544 186 30 53746 102 05)
Gabapentin
Product Images NDC 10544-186
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 10544-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Dc2d0eb8-figure-01 (Dc2d0eb8 Figure 01)
Dc2d0eb8-figure-02 (Dc2d0eb8 Figure 02)
Dc2d0eb8-figure-03 (Dc2d0eb8 Figure 03)
Dc2d0eb8-figure-04 (Dc2d0eb8 Figure 04)
This text displays a table that shows the percentage of responders at endpoint for two different studies, identified as Study 1 and Study 2. However, the purpose or nature of the studies is not available as there is not enough context.*
Dc2d0eb8-figure-05 (Dc2d0eb8 Figure 05)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
